Multiple endocrine neoplasia type 1 laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 1 include increased [[parathyroid hormone]], increased [[gastrin]], and increased [[cortisol]]. | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
* Laboratory tests may be performed periodically to screen for MEN1 tumors | * Laboratory tests may be performed periodically to screen for MEN1 tumors | ||
Revision as of 13:44, 10 September 2015
|
Multiple endocrine neoplasia type 1 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multiple endocrine neoplasia type 1 laboratory findings On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 laboratory findings |
|
FDA on Multiple endocrine neoplasia type 1 laboratory findings |
|
CDC on Multiple endocrine neoplasia type 1 laboratory findings |
|
Multiple endocrine neoplasia type 1 laboratory findings in the news |
|
Blogs on Multiple endocrine neoplasia type 1 laboratory findings |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 1 include increased parathyroid hormone, increased gastrin, and increased cortisol.
Laboratory Findings
- Laboratory tests may be performed periodically to screen for MEN1 tumors
- Parathyroid hormone
- Prolactin
- Insulin
- Urinary calcium to detect the results of excess hormone production
- Gastrin
- Insulin
- Glucose
- C-peptide
- Proinsulin
- Serum cortisol